Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides

被引:36
作者
Di Fabio, S [1 ]
Giannini, G [1 ]
Lapenta, C [1 ]
Spada, M [1 ]
Binelli, A [1 ]
Germinario, E [1 ]
Sestili, P [1 ]
Belardelli, F [1 ]
Proietti, E [1 ]
Vella, S [1 ]
机构
[1] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy
关键词
HIV; sexual transmission; hu-SCID mice; microbicides;
D O I
10.1097/00002030-200111230-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To develop an animal model of vaginal transmission of HIV-1 for the evaluation of vaginal microbicides. Design: Vaginal infection was performed in SCID mice reconstituted with 4 X 10(7) human peripheral blood lymphocytes (hu-PBL) by non-invasive vaginal administration. The hu-PBL were previously infected in vitro with a non-syncytium (NSI) strain of HIV-1 (SF162) (hu-PBL-SCID). Lymphocyte migration in vivo was examined using fluorescently labelled human lymphocytes. Methods: The percentage of CD4 T cells, plasma viral load and p24 antigen were evaluated using fluorescent activated cell sorting (FACS), the Amplicor HIV-1 monitor kit and enzyme-linked immunosorbent assay, respectively. Polymerase chain reaction (PCR) analysis was performed on DNA extracted from spleen and lymph nodes. For in vivo migration of labelled lymphocytes, the mice were sacrified after 4, 24 and 48 h; vaginae and local lymph nodes were removed, snap frozen with OCT, sectioned and examined by fluorescent microscopy and FACS. Results: HIV transmission was established using virus-infected cells inoculated vaginally, as shown by FACS, HIV viral load, p24 and PCR results. Labelled cells were easily located within the vaginal tissues after 4 h. However, few or no cells could be identified after 24 or 48 h at the vaginal level, whereas labelled cells could be detected at the level of regional lymph nodes. Conclusions: Because of its simplicity and practical features compared with other animal models, the vaginal HIV-infected hu-SCID mouse model may prove useful to test the activity of compounds against cell-associated HIV and, possibly, other sexually transmitted diseases. (C) 2001 Lippincott Williams Wilkins.
引用
收藏
页码:2231 / 2238
页数:8
相关论文
共 28 条
[1]   Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier [J].
Bomsel, M .
NATURE MEDICINE, 1997, 3 (01) :42-47
[2]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P889
[3]   HIV prevention in developed countries [J].
Coates, TJ ;
Aggleton, P ;
Gutzwiller, F ;
DesJarlais, D ;
Kihara, M ;
Kippax, S ;
Schechter, M ;
vandenHoek, JAR .
LANCET, 1996, 348 (9035) :1143-1148
[4]   Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides [J].
Greenhead, P ;
Hayes, P ;
Watts, PS ;
Laing, KG ;
Griffin, GE ;
Shattock, RJ .
JOURNAL OF VIROLOGY, 2000, 74 (12) :5577-5586
[5]   Potential for the transmission of HIV-1 despite highly active antiretroviral therapy [J].
Haase, AT ;
Schacker, TW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25) :1846-1848
[6]   Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells [J].
Hu, JJ ;
Gardner, MB ;
Miller, CJ .
JOURNAL OF VIROLOGY, 2000, 74 (13) :6087-6095
[7]   Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes [J].
Ibata, B ;
Parr, EL ;
King, NJC ;
Parr, MB .
BIOLOGY OF REPRODUCTION, 1997, 56 (02) :537-543
[8]   PERSISTENT INFECTION OF NORMAL MICE WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
LOCARDI, C ;
PUDDU, P ;
FERRANTINI, M ;
PARLANTI, E ;
SESTILI, P ;
VARANO, F ;
BELARDELLI, F .
JOURNAL OF VIROLOGY, 1992, 66 (03) :1649-1654
[9]  
Mascola LR, 2000, AIDS, V14, pS167
[10]   Science, medicine, and the future - Microbicides in HIV prevention [J].
McCormack, S ;
Hayes, R ;
Lacey, CJN ;
Johnson, AM .
BRITISH MEDICAL JOURNAL, 2001, 322 (7283) :410-413